Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 108
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing | Dr Sundeep Prabhakar Chepuri, Assistant Professor, Indian Institute of Science (IISc), Bengaluru | 2020 | Drug repurposing for COVID-19 | |
| Preclinical studies and process development for production of Tridecaptin M, an antibiotic against colistin resistant Gram negative bacterial infections | Dr Hemraj Nandanwar, ScientistI, CSIR-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Genetic engineering to treat gram negative bacterial infections |
| Design of novel bactericidal molecules targeting a conserved bacterial transcription regulator | Dr Ranjan Sen, Scientist, Centre for DNA Fingerprinting and Diagnostics (CDFD), Telangana | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug design |
| Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A baumannii | Dr Sidharth Chopra, Scientist, Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Drug discovery |
| Determination of biofilm pharmacodynamics of newly formulated, nano-conjugated antibiotics to optimize treatment and dosing of chronic, antibiotic-resistant biofilm infections | Dr Gopal Chandra Kundu, Scientist & Director, National Centre for Cell Science (NCCS), Maharashtra | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Pharmacodynamics |
| Development of Monitoring and Evaluation protocol for accelerated MDA (Mass Drug Administration) with IDA (Ivermectin, Diethylcarbamazine and Albendazole) for lymphatic filariasis elimination programme | Dr Jambulingam P, Director, Vector Control Research Centre (ICMR-VCRC), Puducherry | 2019 | Bill & Melinda Gates Foundation (BMGF), USA | Filariasis; Biostatistics |
| Virtual National Oral Cancer Institute (VNOCI) | Dr. Kodaganur S Gopinath, Surgical Oncologist, Bengaluru Institute Of Oncology, Prof. Saumyadipta Pyne, Scientific Director, Indian Institute of Public Health (IIPH), Hyderabad, Dr. Annapoorni Rangarajan, Assistant Professor, Indian Institute of Science (IISc), Bengaluru, Dr. Ramaswamy Subramanian, Professor, Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Prof. Tapas K Kundu,Professor, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, Dr. Birendranath Banerjee, Associate Professor, Kalinga Institute of Industrial Technology (KIIT), Bhubaneswar, Dr. Rekha V Kumar, Professor, Kidwai Memorial Institute of Oncology (KMIO), Bengaluru, Prof. Partha Pratim Majumder, Professor, National Institute of Biomedical Genomics (NIBG), Kalyani Dr. Anupam Chatterjee, Professor, North-Eastern Hill University (NEHU), Shillong, Dr. Tessy Thomas Maliekal, Scientist, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Development of PD-1/PDL-1 check point inhibitor(s) for adjuvant therapy | Dr. C Gopi Mohan, Associate Professor, Amrita Vishwa Vidyapeetham Amritapuri Campus (AVVAC), Kollam | 2018 | Department of Biotechnology (DBT), Government of India, New Delhi | Adjuvant therapy |
| Engagement of Clinical Development Services Agency (CDSA) for monitoring cum management of clinical cohort study (ADBS) at NIMHANS, Bengaluru | Prof. Apurva Sarin, Professor, Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Dr. Nitya Wadhwa, Assistant Professor, Translational Health Science and Technology Institute (THSTI), Faridabad | 2018 | Department of Biotechnology (DBT), Government of Inida | NA |
| Pharmacological and Molecular Approaches to Investigate Selected Drug in Model of Ischemia-Reperfusion Injury in Streptozotocin Induced Diabetic Rats | Prof Dharamvir Singh Arya, All India Institute of Medical Sciences (AIIMS), New Delhi | 2018 | Bristol-Myers Squibb (BMS) Company, USA | Pharmacology |